Filing Details
- Accession Number:
- 0001209191-18-001575
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-03 20:08:13
- Reporting Period:
- 2018-01-02
- Accepted Time:
- 2018-01-03 20:08:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1444811 | N Jonathan Rubin | 55 Nod Road Avon CT 06001 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-01-02 | 17,443 | $53.72 | 43,890 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Disposition | 2018-01-02 | 17,443 | $96.07 | 26,447 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2018-01-02 | 17,443 | $0.00 | 17,443 | $53.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
53,850 | 2025-11-02 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $95.15 to $97.00, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- All of the stock options in this tranche have vested in full.
- Of the remainder of 53,850 options in this tranche, 30,086 are currently exercisable. The remainder of 23,764 options shall vest on November 2, 2018.
- Not applicable.